These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 400749)

  • 1. Renal vein renin and saralasin testing in renovascular hypertension.
    MacCarthy EP; Stokes GS
    Am Heart J; 1978 Nov; 96(5):697-8. PubMed ID: 400749
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of angiotensin II analogue on rabbits with acute and chronic two-kidney, one clip hypertension (author's transl)].
    Yamasaki S; Nakatani H; Kusunoki K; Kawashima T; Kawamura H; Ohara T; Shintani H; Taniguchi N; Nagai T
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1251-63. PubMed ID: 396405
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of surgical response in renovascular hypertension using angiotensin II blockade.
    Buda JA; Baer L; Arora SP; Parra-Carrillo JZ; Radichevich I
    Surgery; 1978 Nov; 84(5):664-70. PubMed ID: 715682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of saralasin to predict a response to surgery in renovascular hypertension.
    Thomas RD; Ball SG; Lee MR
    Lancet; 1977 Apr; 1(8014):724-6. PubMed ID: 66520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on diagnostic usefulness of stimulated plasma renin activity and saralasin test in detection of renovascular hypertension.
    Anderson GH; Springer J; Randall P; Streeten DH; Blakeman N
    Lancet; 1980 Oct; 2(8199):821-4. PubMed ID: 6107499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L; Martorana G; Giberti C
    Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J; Liebau G; Steiner B; Hayduk K
    Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-negative saralasin responses in renovascular hypertension.
    Stokes GS; MacCarthy EP; Frost GW; Sheil AG
    Br J Urol; 1979 Apr; 51(2):92-9. PubMed ID: 465980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The saralasin test. Use in diagnosis of nephrovascular hypertension].
    Pigliucci GM; Falappa P; Martino F
    Minerva Cardioangiol; 1979 Sep; 27(9):551-8. PubMed ID: 398451
    [No Abstract]   [Full Text] [Related]  

  • 16. Pheochromocytoma and vasodepressor response to saralasin.
    Zawada ET; Dornfeld L; Maxwell M; Marks L; Kaufman JJ
    Ann Intern Med; 1979 Sep; 91(3):494-5. PubMed ID: 475193
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH; Varady P; Zawada ET; Burkhalter JF; Waks U; Marks L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
    [No Abstract]   [Full Text] [Related]  

  • 19. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR; Ribeiro AB; Gorkin JU; Felton KR
    Am J Cardiol; 1980 Mar; 45(3):609-13. PubMed ID: 6986750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM; Wilson JP; Slaton PE; Foster JH; Liddle GW; Hollifield JW
    Ann Intern Med; 1977 Jul; 87(1):36-42. PubMed ID: 879617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.